Dr. Avik Biswas | Virology | Best Researcher Award
Senior Scientific Officer at Chitaranjan National Cancer Institute, India
Dr. Avik Biswas, based in Kolkata, India, is currently associated with the Chittaranjan National Cancer Institute (CNCI). With a Ph.D. in Biotechnology from the University of Calcutta and extensive postdoctoral experience in the USA, he has established himself as a prominent researcher in the field of virology, particularly focusing on hepatitis viruses.
Profile
Dr. Biswas’s academic journey began with a BSc in Microbiology, followed by an MSc in Biotechnology. He completed his Ph.D. in Biotechnology from the University of Calcutta in 2013. His strong academic background laid the foundation for his subsequent research endeavors.
Dr. Biswas has held several research positions at prestigious institutions, both in India and the USA. He is currently serving as a Senior Scientific Officer at CNCI, Kolkata, since August 2018. His previous roles include Research Associate positions at Saint Louis University, The Scripps Research Institute, and a Postdoctoral Fellowship at Tulane University. His extensive experience in both academic and research institutions has provided him with a robust platform for his research activities.
Research Interests
Dr. Biswas has made significant contributions to the field of virology, particularly in the study of hepatitis B virus (HBV) and its implications in liver diseases. His work has led to a deeper understanding of the molecular interactions between HBV and host cells, which has implications for the development of therapeutic strategies. He has authored or co-authored 32 peer-reviewed publications, contributing to the scientific community’s understanding of HBV and other viral infections.
Membership in Professional Societies
Dr. Biswas is a life member of several professional societies, including the Indian Association for Cancer Research (IACR) and the Society of Biological Chemists (SBC). He is also affiliated with international organizations such as the American Society for Microbiology (ASM) and the American Society for Virology (ASV), highlighting his global engagement in the field of virology.
Conclusion
Dr. Avik Biswas is a highly accomplished researcher with a solid academic background, extensive professional experience, and significant contributions to the field of virology. His work on hepatitis B virus and its implications for liver diseases has had a considerable impact on the scientific community. Given his research achievements, professional recognition, and ongoing contributions to the field, Dr. Biswas is a highly suitable candidate for the Research for Best Researcher Award. His dedication to advancing scientific knowledge and his active involvement in ongoing research projects make him an exemplary candidate for this prestigious award.
Publications Top Notes
Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur
Authors: R Panigrahi, A Biswas, S Datta, A Banerjee, PK Chandra, PK Mahapatra
Journal: Virology Journal
Citations: 86
Year: 2010
Subgenotypes of hepatitis B virus genotype D (D1, D2, D3, and D5) in India: differential pattern of mutations, liver injury, and occult HBV infection
Authors: PK Chandra, A Biswas, S Datta, A Banerjee, R Panigrahi, S Chakrabarti
Journal: Journal of Viral Hepatitis
Citations: 85
Year: 2009
Tumor suppressor microRNA miR-145 and onco microRNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes
Authors: M Bandopadhyay, A Banerjee, N Sarkar, R Panigrahi, S Datta, A Pal
Journal: BMC Cancer
Citations: 76
Year: 2014
Frequency and significance of hepatitis B virus surface gene variant circulating among ‘anti-HBc only’ individuals in Eastern India
Authors: A Banerjee, PK Chandra, S Datta, A Biswas, P Bhattacharya
Journal: Journal of Clinical Virology
Citations: 61
Year: 2007
Expression of microRNA‐155 correlates positively with the expression of Toll‐like receptor 7 and modulates hepatitis B virus via C/EBP‐β in hepatocytes
Authors: N Sarkar, R Panigrahi, A Pal, A Biswas, SP Singh, SK Kar
Journal: Journal of Viral Hepatitis
Citations: 57
Year: 2015
Oregano oil and its principal component, carvacrol, inhibit HIV-1 fusion into target cells
Authors: S Mediouni, JA Jablonski, S Tsuda, A Barsamian, C Kessing, A Richard
Journal: Journal of Virology
Citations: 50
Year: 2020
A massively parallel selection of small molecule-RNA motif binding partners informs the design of an antiviral from sequence
Authors: JL Childs-Disney, T Tran, BR Vummidi, SP Velagapudi, HS Haniff
Journal: Chem
Citations: 50
Year: 2018
Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R
Authors: S Datta, R Panigrahi, A Biswas, PK Chandra, A Banerjee, PK Mahapatra
Journal: Journal of Virology
Citations: 50
Year: 2009
Analysis of hepatitis B virus X gene phylogeny, genetic variability, and its impact on pathogenesis: implications in Eastern Indian HBV carriers
Authors: S Datta, A Banerjee, PK Chandra, A Biswas, R Panigrahi, PK Mahapatra
Journal: Virology
Citations: 47
Year: 2008
Molecular epidemiology and clinical significance of hepatitis B virus genotypes, core promoter, and precore mutations in eastern India
Authors: S Datta, A Biswas, PK Chandra, A Banerjee, R Panigrahi, PK Mahapatra
Journal: Intervirology
Citations: 35
Year: 2008